Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: Prevalence and Quality of Life
|ClinicalTrials.gov Identifier: NCT01423071|
Recruitment Status : Completed
First Posted : August 25, 2011
Last Update Posted : June 18, 2015
|Condition or disease|
|Hypertension, Pulmonary Pulmonary Disease, Chronic Obstructive|
|Study Type :||Observational|
|Actual Enrollment :||220 participants|
|Observational Model:||Case Control|
|Official Title:||Chronisch Obstruktive Lungenerkrankung Und Pulmonale Hypertonie: Prävalenz Und Lebensqualität|
|Study Start Date :||August 2011|
|Primary Completion Date :||January 2015|
|Study Completion Date :||January 2015|
COPD with PH
COPD patients with confirmed diagnosis of PH.
COPD without PH
COPD patients without confirmed diagnosis of PH
PAH without COPD
PAH patients who do not suffer from COPD
- Prevalence of PH [ Time Frame: At baseline ]Prevalence of PH as defined by ESC/ERS guidelines (mean pulmonary arterial pressure ≥25 mmHg, assessed by right-heart catheterization) among the subgroup of COPD GOLD III and IV patients.
- Quality of life [ Time Frame: One year ]Explorative data analysis to assess correlation between quality of life and PH, by comparison of COPD patients with and without PH and a reference group of patients with only PAH.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01423071
|Bethanien Hospital, Clinic for Pneumology and Allergology, Center for Sleep Medicine and Respiratory Care, Institute for Pneumology at the University Witten/Herdecke|
|Solingen, NRW, Germany, 42699|
|Principal Investigator:||Winfried J Randerath, Prof. Dr. med.||Wissenschaftliches Institut Bethanien e.V|